Penn Medicine Provider
Radiation Oncology
Suneel N. Nagda, MD
5.0
(147)
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Pennsylvania Hospital

About me

  • Department Chair, Pennsylvania Hospital, Radiation Oncology
  • Vice Chair, Quality and Safety, Radiation Oncology
  • Regional Network Medical Director, Radiation Oncology
  • Associate Professor of Clinical Radiation Oncology

Education and training

  • Medical School: University of Maryland School of Medicine
  • Residency: University of Illinois Medical Center
  • Residency: Loyola University Medical Center

What my patients think about me

Average Rating
5.0

147 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
because i was in out explained everything that's going to happen soon .
April 2025
5.0
5.0
professional, courteous and patient
March 2025
5.0
5.0
very personable and extremely knowledgeable and put me at ease.
March 2025
5.0
5.0
dr nagda was very knowledgeable and communicates well

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Nagda is a Penn Medicine physician.

Qualifications and experience

My research

Baumann BC, Bernstein KA, DeLaney TF, Simone CB 2nd, Kolker JD, Choy E, Levin WP, Weber KL, Muniappan A, Berman AT, Staddon A, Hartner L, Van Tine B, Hirbe A, Glatstein E, Hahn SM, Nagda SN, Chen YL. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity , J Surg Oncol: 2020


Bekelman JE1, Lu H2, Pugh S3, Baker K4, Berg CD5, de Gonzalez AB5, Braunstein LZ6, Bosch W7, Chauhan C8, Ellenberg S9, Fang LC10, Freedman GM2, Hahn EA11, Haffty BG12, Khan AJ6, Jimenez RB13, Kesslering C14, Ky B15, Lee C5, Lu HM13, Mishra MV4, Mullins CD16, Mutter RW17, NAGDA SN, Pankuch M14, Powell SN6, Prior FW18, Schupak K6, Taghian AG13, Wilkinson JB19, MacDonald SM13, Cahlon O6; RadComp (Radiotherapy Comparative Effectiveness Consortium). Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol. , BMJ Open, 9(10): 2019,e025556


W. Tristram Arscott, MD; Kathleen Gray, RN; Dennis Kuska, RN; Suneel Nagda, MD; Robert Lustig, MD; Michelle Alonso-Basanta, MD PhD; James M. Metz, MD; Joshua Jones, MD, MA Evaluating the impact of secure mobile messaging on communication and cancer care team satisfaction in a large radiation oncology clinic , Journal of Oncology Practice, 15(8): 2019,e733-e738


Ruangkanchanasetr R, Lee JYK, NAGDA SN, Geiger GA, Kolker JD, Bigelow DC, Ruckenstein MJ, Nasrallah M5, Alonso-Basanta M. Toxicity of Gamma Knife Radiosurgery May Be Greater in Patients with Lower Cranial Nerve Schwannomas. , J Neurol Surg B Skull Base, 79(6): 2018


Gui Hongxing, Lhospital Elliott, Staddon Arthur P, NAGDA SN, Zager Eric L, Zhang Paul J L, Brooks John S Combined Sclerosing and Spindle Cell Rhabdomyosarcoma in Previous Craniotomy Site: A Case Report and a Review of the Literature. , International journal of surgical pathology: 2018,1066896918802030


Guttmann DM, Gabriel P, Kennedy C, Rate W, Grizos W, NAGDA SN, Wojtowicz L, Lin L, Freedman GM Comparison of acute toxicities between contemporary forward-planned 3D conformal radiotherapy and inverse-planned intensity-modulated radiotherapy for whole breast radiation , Breast J, 24(2): 2018,128-132


Alite F, Stang K, Balasubramanian N, Adams W, Shaikh M, Small C, Sethi A, NAGDA SN, Emami B, Harkenrider M Local control dependence on consecutive vs. nonconsecutive fractionation in lung stereotactic body radiation therapy. , Radiother Oncol, 121(1): 2016,9-14


Baumann BC, NAGDA SN, Kolker JD, Levin WP, Weber KL, Berman AT, Staddon A, Hartner L, Hahn SM, Glatstein E, Simone CB Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection. , J Surg Oncol, 114(1): 2016,65-9


Chowdhury IH, Ojerholm E, McMillan MT, Miller De, Kolker JD, Kurtz G, Dorsey JF, NAGDA SN, Geiger GA, Brem S, O'Rourke DM, Zager EL, Gangadhar T, Schuchter L, Lee JY, Alonso-Basanta M Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases. , Radiat Oncol, 10: 2015,248


Vogel J, Ojerholm E, Hollander A, Briola C, Mooij R, Bieda M, Kolker J, NAGDA SN, Geiger G, Dorsey J, Lustig R, O'Rourke DM, Brem S, Lee J, Alonso-Basanta M Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases. , Radiat Oncol, 10: 2015,221